HALISTER: Regeneron Eye Drug’s Advantage Over Roche’s Narrowed in Trial

Regeneron Eye Drug’s Advantage Over Roche’s Narrowed in Trial

Alert: HALISTER
Source: BN (Bloomberg News)

Tickers
ROG VX (Roche Holding AG)
REGN US (Regeneron Pharmaceuticals Inc)

People
Leonard Schleifer (Regeneron Pharmaceuticals Inc)

To de-activate this alert, click here
To modify this alert, click here

UUID: 7947283